You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 20, 2024

Claims for Patent: 10,131,667

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 10,131,667

Title:	Substituted tricyclic compounds as FGFR inhibitors
Abstract:	The present invention relates to tricyclic compounds, and pharmaceutical compositions of the same, that are inhibitors of one or more FGFR enzymes and are useful in the treatment of FGFR-associated diseases such as cancer.
Inventor(s):	Wu; Liangxing (Wilmington, DE), Zhang; Colin (Berwyn, PA), He; Chunhong (Chadds Ford, PA), Lu; Liang (Hockessin, DE), Yao; Wenqing (Chadds Ford, PA)
Assignee:	Incyte Corporation (Wilmington, DE)
Application Number:	15/408,768
Patent Claims:	1. A method of treating cancer in a patient comprising administering to said patient a therapeutically effective amount of 3-(2,6-difluoro-3,5-dimethoxyphenyl)-1-ethyl-8-(morpholin-4-ylmethyl)-1,3- ,4,7-tetrahydro-2H-pyrrolo[3',2':5,6]pyrido[4,3-d]pyrimidin-2-one, or a pharmaceutically acceptable salt thereof, wherein said cancer is selected from bladder cancer, breast cancer, endometrial cancer, gastric cancer, lung cancer, non-small cell lung cancer, adenocarcinoma, multiple myeloma, myeloproliferative neoplasms (MPN), esophageal cancer, head and neck cancer, glioblastoma, ovarian cancer, cervical cancer and liver cancer. 2. The method of claim 1, wherein the cancer is bladder cancer. 3. The method of claim 1, wherein the cancer is breast cancer. 4. The method of claim 1, wherein the cancer is endometrial cancer. 5. The method of claim 1, wherein the cancer is gastric cancer. 6. The method of claim 1, wherein the cancer is lung cancer. 7. The method of claim 1, wherein the cancer is non-small cell lung cancer. 8. The method of claim 1, wherein the cancer is adenocarcinoma. 9. The method of claim 1, wherein the cancer is myeloproliferative neoplasms (MPN). 10. The method of claim 1, wherein the cancer is multiple myeloma. 11. The method of claim 1, wherein the cancer is esophageal cancer. 12. The method of claim 1, wherein the cancer is head and neck cancer. 13. The method of claim 1, wherein the cancer is glioblastoma. 14. The method of claim 1, wherein the cancer is ovarian cancer. 15. The method of claim 1, wherein the cancer is cervical cancer. 16. The method of claim 1, wherein the cancer is liver cancer.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.